TuHURA Biosciences, Inc./NV HURA

About TuHURA Biosciences, Inc./NV (HURA): stock profile, AI score and financials

TuHURA Biosciences, Inc./NV (HURA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. HURA is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q4 2026), TuHURA Biosciences, Inc./NV reports net income of $-9.2M, free cash flow of $-8.8M. Top institutional holders of HURA by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, NORTHERN, BlackRock, based on the most recent SEC filings. HURA trades on the Nasdaq exchange and files with the SEC under CIK 1498382. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HURA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TuHURA Biosciences, Inc./NV directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1498382 →